The AP (10/15) reported, “Mylan Inc. said Thursday it received regulatory approval for its version of Johnson & Johnson’s epilepsy drug Topamax [topiramate], and began shipping” the “15 milligram and 25 milligram topiramate sprinkle capsules.” The patents “on Topamax expired in March,” and the AP notes that “Teva Pharmaceutical Industries Ltd. also markets a generic version of the drug.”
FDA approves Topamax generic.
October 16, 2009 by abrandemihl
About the author
-
Blog Stats
- 235,084 hits
Twitter
- Use Of ADD/ADHD Meications Lower Likelihood Of Crime wp.me/ppe9o-pV 10 years ago
Categories
Recent Comments
Patient Assistance Programs For Free Medications
Buckeye Psychiatry
Buckeye Psychiatry, LLC 
Leave a Reply